{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:32:21Z","timestamp":1770348741524,"version":"3.49.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/ftd.0b013e31828f5088","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T14:35:59Z","timestamp":1379601359000},"page":"631-642","source":"Crossref","is-referenced-by-count":31,"title":["Clinical Pharmacology Quality Assurance Program"],"prefix":"10.1097","volume":"35","author":[{"given":"Robin","family":"DiFrancesco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam G.","family":"Pande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Siminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Jenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene D.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1373\/clinchem.2011.168641","article-title":". Proficiency testingexternal quality assessment: current challenges and future directions.","volume":"57","author":"Miller","year":"2011","journal-title":"Clin Chem"},{"key":"R2-10-20210129","first-page":"412","article-title":"Hekster YA, et al..","volume":"27","author":"Droste","year":"2005","journal-title":"TDM: therapeutic drug measuring or therapeutic drug monitoring Ther Drug Monit"},{"key":"R3-10-20210129","first-page":"741","article-title":"Boucher CA, et al..","volume":"63","author":"Aarnoutse","year":"2003","journal-title":"Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs Drugs"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/AAC.46.3.884-886.2002","article-title":". International interlaboratory quality control program for measurement of antiretroviral drugs in plasma.","volume":"46","author":"Aarnoutse","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00126334-200303010-00007","article-title":". Evaluation of antiretroviral drug measurements by an interlaboratory quality control program.","volume":"32","author":"Droste","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/FTD.0b013e31820fa528","article-title":". The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program.","volume":"33","author":"Burger","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/AAC.00901-08","article-title":". International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.","volume":"53","author":"Bruggemann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.48.3.824-831.2004","article-title":". Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.","volume":"48","author":"Holland","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.ftd.0000211817.58052.b8","article-title":". Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.","volume":"28","author":"Holland","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.5858\/2001-125-0729-AEOAGF","article-title":". An evaluation of analytical goals for assays of drugs.","volume":"125","author":"Steele","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5858\/2005-129-997-PCOSRF","article-title":". Performance characteristics of several rules for self-interpretation of proficiency testing data.","volume":"129","author":"Carey","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"R12-10-20210129","first-page":"437","article-title":"The detection of problem analytes in a single proficiency test challenge in the absence of the Health Care Financing Administration rule violations.","volume":"17","author":"Cembrowski","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"R13-10-20210129","first-page":"7002","article-title":"Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA).","volume":"57","year":"1992","journal-title":"Fed Regist"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/clinchem\/46.1.89","article-title":"Causes of unsatisfactory performance in proficiency testing.","volume":"46","author":"Jenny","year":"2000","journal-title":"Clin Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31828f5088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T12:31:45Z","timestamp":1646569905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201310000-00010"}},"subtitle":["Models for Longitudinal Analysis of Antiretroviral Proficiency Testing for International Laboratories"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31828f5088","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}